EP2044091A4 - COMPOUNDS FOR TREATING A PERIODONTAL DISEASE - Google Patents

COMPOUNDS FOR TREATING A PERIODONTAL DISEASE

Info

Publication number: EP2044091A4
Authority: EP; European Patent Office
Prior art keywords: treating; compounds; periodontal disease; periodontal; disease
Prior art date: 2006-06-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP07812123A

Other languages

German (de)

French (fr)

Other versions

EP2044091A2 (en

Inventor

Virginia Sanders

Kirk R Maples

Jacob J Plattner

Carolyn Bellinger-Kawahara

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Anacor Pharmaceuticals LLC

Original Assignee

Anacor Pharmaceuticals LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-12

Filing date

2007-06-12

Publication date

2010-08-04

2007-06-12 Application filed by Anacor Pharmaceuticals LLC filed Critical Anacor Pharmaceuticals LLC

2009-04-08 Publication of EP2044091A2 publication Critical patent/EP2044091A2/en

2010-08-04 Publication of EP2044091A4 publication Critical patent/EP2044091A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Birds (AREA)
Medicinal Chemistry (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Oral & Maxillofacial Surgery (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

EP07812123A 2006-06-12 2007-06-12 COMPOUNDS FOR TREATING A PERIODONTAL DISEASE Withdrawn EP2044091A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US80450406P	2006-06-12	2006-06-12
US82389306P	2006-08-29	2006-08-29
PCT/US2007/071049 WO2007146965A2 (en)	2006-06-12	2007-06-12	Compounds for the treatment of periodontal disease

Publications (2)

Publication Number	Publication Date
EP2044091A2 EP2044091A2 (en)	2009-04-08
EP2044091A4 true EP2044091A4 (en)	2010-08-04

Family

ID=38832802

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP07812123A Withdrawn EP2044091A4 (en)	2006-06-12	2007-06-12	COMPOUNDS FOR TREATING A PERIODONTAL DISEASE

Country Status (9)

Country	Link
EP (1)	EP2044091A4 (en)
KR (1)	KR20090029797A (en)
AU (1)	AU2007257689A1 (en)
BR (1)	BRPI0713010A2 (en)
CA (1)	CA2654449A1 (en)
IL (1)	IL195571A0 (en)
MX (1)	MX2008015918A (en)
RU (1)	RU2008152367A (en)
WO (1)	WO2007146965A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT3424932T (en)	2005-02-16	2021-05-19	Anacor Pharmaceuticals Inc	Boronophthalides for therapeutic use
JP2009526751A (en)	2005-12-30	2009-07-23	アナコールファーマシューティカルズ，インコーポレイテッド	Boron-containing small molecule
RU2508113C2 (en)	2006-02-16	2014-02-27	Анакор Фармасьютикалз, Инк.	Boron-based small molecules as anti-inflammatory drugs
JO3598B1 (en)	2006-10-10	2020-07-05	Infinity Discovery Inc	Boronic acids and esters as inhibitors of fatty acid amide hydrolase
JO3396B1 (en)	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	Boron-containing small molecules
KR20150065941A (en)	2008-03-06	2015-06-15	아나코르 파마슈티칼스 인코포레이티드	Boron-containing small molecules as anti-inflammatory agents
WO2009126691A1 (en)	2008-04-09	2009-10-15	Infinity Pharmaceuticals, Inc	Inhibitors of fatty acid amide hydrolase
JP5606913B2 (en) *	2008-08-11	2014-10-15	独立行政法人科学技術振興機構	Protein cross-linking inhibitor
WO2010028005A1 (en)	2008-09-04	2010-03-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
EP2348863A4 (en)	2008-09-04	2012-03-07	Anacor Pharmaceuticals Inc	SMALL MOLECULES CONTAINING BORON
US9493489B2 (en)	2008-10-15	2016-11-15	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agents
PE20120052A1 (en)	2008-12-17	2012-02-13	Anacor Pharmaceuticals Inc	(S) -3-AMINO-METHYL-7- (3-HYDROXY-PROPOXY) -3H-BENZO- [C] [1,2] -OXABOROL-1-OL POLYMORPHES
ES2493916T3 (en)	2009-04-07	2014-09-12	Infinity Pharmaceuticals, Inc.	Inhibitors of fatty acid amide hydrolase
AU2010234449A1 (en)	2009-04-07	2011-11-03	Infinity Pharmaceuticals, Inc.	Inhibitors of fatty acid amide hydrolase
TW201109022A (en) *	2009-06-03	2011-03-16	Colgate Palmolive Co	Borinic compositions
US8343944B2 (en)	2009-07-28	2013-01-01	Anacor Pharmaceuticals, Inc.	Trisubstituted boron-containing molecules
WO2011019618A1 (en)	2009-08-14	2011-02-17	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
WO2011049971A1 (en)	2009-10-20	2011-04-28	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
US20110212918A1 (en)	2009-11-11	2011-09-01	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2011063293A1 (en) *	2009-11-20	2011-05-26	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antihelminth agents
RU2414210C1 (en) *	2009-12-28	2011-03-20	Общество С Ограниченной Ответственностью "Сплат-Косметика" (Ооо "Сплат-Косметика")	Medication for removal of tobacco resins and based on it composition
US8716478B2 (en)	2010-01-27	2014-05-06	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2011097233A1 (en)	2010-02-03	2011-08-11	Infinity Pharmaceuticals, Inc.	Fatty acid amide hydrolase inhibitors
US8623911B2 (en)	2010-03-19	2014-01-07	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agent
CN108610356B (en)	2010-09-07	2021-02-26	阿纳科制药公司	Benzoxaborole Derivatives for the Treatment of Bacterial Infections
AR088668A1 (en) *	2011-11-21	2014-06-25	Lilly Co Eli	SMALL MOLECULES CONTAINING BORO
US8669207B1 (en)	2013-01-30	2014-03-11	Dow Agrosciences, Llc.	Compounds and compositions
US10070649B2 (en)	2013-01-30	2018-09-11	Agrofresh Inc.	Volatile applications against pathogens
NZ710723A (en)	2013-01-30	2019-12-20	Agrofresh Inc	Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts
US11039617B2 (en)	2013-01-30	2021-06-22	Agrofresh Inc.	Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en)	2013-01-30	2017-03-07	Agrofresh Inc.	Volatile applications against pathogens
WO2016001834A1 (en)	2014-07-01	2016-01-07	Daiichi Sankyo Company, Limited	Tricyclic benzoxaboroles as antibacterial agents
TW201735792A (en)	2016-03-07	2017-10-16	農業保鮮股份有限公司	Synergistic method using a benzoxaborole compound and an antiseptic gas as an antimicrobial agent for crops
US11447506B2 (en)	2016-05-09	2022-09-20	Anacor Pharmaceuticals, Inc.	Crystal forms of crisaborole in free form and preparation method and use thereof
CA3023851C (en) *	2016-05-09	2021-01-26	Anacor Pharmaceuticals, Inc.	Crystal forms of crisaborole in free form and preparation method and use thereof
CN107759625B (en) *	2016-08-22	2020-12-29	药源药物化学（上海）有限公司	Preparation method of 4- (1-hydroxy-1, 3-dihydrobenzo [ c ] [1,2] oxaborole-5-yloxy) benzonitrile
US10961261B2 (en)	2017-03-01	2021-03-30	Anacor Pharmaceuticals, Inc.	Oxaborole analogs and uses thereof
EP3576747A4 (en) *	2017-03-09	2020-12-16	The Penn State Research Foundation	Boron-containing small molecules for inhibiting activity of a receptor-like protein tyrosine phosphatase
CN110183477B (en) *	2019-07-03	2022-03-04	石家庄诚志永华显示材料有限公司	Organic electroluminescent compounds and their applications
US20230340530A1 (en)	2020-08-31	2023-10-26	Pfizer Inc.	Methods of Protecting RNA
KR102638321B1 (en) *	2022-01-27	2024-02-19	마이크로바이오헬스케어 주식회사	Novel compound with anti-biofilm formation activity and use of the same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1155698A1 (en) *	1999-01-29	2001-11-21	Nitto Kasei Co., Ltd.	Organoboron compounds exhibiting anticoccidial activities
WO2004056322A2 (en) *	2002-12-18	2004-07-08	Anacor Pharmaceuticals, Inc.	Antibiotics containing borinic acid complexes and methods of use
WO2005021559A2 (en) *	2003-09-02	2005-03-10	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Oxazaborolidines as bacteria effectors
WO2005123095A1 (en) *	2004-06-14	2005-12-29	Anacor Pharmaceuticals, Inc.	Anti-parasitic uses of borinic acid complexes
WO2005123094A2 (en) *	2004-06-14	2005-12-29	Anacor Pharmaceuticals, Inc.	Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones
WO2006007384A2 (en) *	2004-06-14	2006-01-19	Anacor Pharmaceuticals, Inc.	Antibiotics containing borinic acid complexes and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4716035A (en) *	1985-05-24	1987-12-29	The Procter & Gamble Company	Oral compositions and methods for treating gingivitis

2007
- 2007-06-12 EP EP07812123A patent/EP2044091A4/en not_active Withdrawn
- 2007-06-12 WO PCT/US2007/071049 patent/WO2007146965A2/en not_active Ceased
- 2007-06-12 CA CA002654449A patent/CA2654449A1/en not_active Abandoned
- 2007-06-12 KR KR1020097000565A patent/KR20090029797A/en not_active Withdrawn
- 2007-06-12 RU RU2008152367/15A patent/RU2008152367A/en not_active Application Discontinuation
- 2007-06-12 AU AU2007257689A patent/AU2007257689A1/en not_active Abandoned
- 2007-06-12 BR BRPI0713010-4A patent/BRPI0713010A2/en not_active IP Right Cessation
- 2007-06-12 MX MX2008015918A patent/MX2008015918A/en unknown
2008
- 2008-11-27 IL IL195571A patent/IL195571A0/en unknown

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1155698A1 (en) *	1999-01-29	2001-11-21	Nitto Kasei Co., Ltd.	Organoboron compounds exhibiting anticoccidial activities
WO2004056322A2 (en) *	2002-12-18	2004-07-08	Anacor Pharmaceuticals, Inc.	Antibiotics containing borinic acid complexes and methods of use
WO2005021559A2 (en) *	2003-09-02	2005-03-10	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Oxazaborolidines as bacteria effectors
WO2005123095A1 (en) *	2004-06-14	2005-12-29	Anacor Pharmaceuticals, Inc.	Anti-parasitic uses of borinic acid complexes
WO2005123094A2 (en) *	2004-06-14	2005-12-29	Anacor Pharmaceuticals, Inc.	Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones
US20060009422A1 (en) *	2004-06-14	2006-01-12	David Perry	Boron-containing compounds and methods of use
WO2006007384A2 (en) *	2004-06-14	2006-01-19	Anacor Pharmaceuticals, Inc.	Antibiotics containing borinic acid complexes and methods of use

Also Published As

Publication number	Publication date
CA2654449A1 (en)	2007-12-21
IL195571A0 (en)	2009-09-01
WO2007146965A2 (en)	2007-12-21
WO2007146965A3 (en)	2008-12-04
BRPI0713010A2 (en)	2012-10-09
KR20090029797A (en)	2009-03-23
EP2044091A2 (en)	2009-04-08
RU2008152367A (en)	2010-07-20
MX2008015918A (en)	2009-01-14
AU2007257689A1 (en)	2007-12-21

Publication	Publication Date	Title
EP2044091A4 (en)	2010-08-04	COMPOUNDS FOR TREATING A PERIODONTAL DISEASE
EP2091329A4 (en)	2011-02-23	INDAZOLE COMPOUNDS
EP1919287A4 (en)	2010-04-28	ORGANIC COMPOUNDS FOR TREATING A REDUCED DOPAMINE RECEPTOR ACTIVITY SIGNAL
EP2200441A4 (en)	2011-01-05	COMPOSITION AND METHOD FOR PREVENTING ORAL DISEASE
EP1966183A4 (en)	2010-12-29	HETEROAROMATIC COMPOUNDS AS DELTA-9 DEATURASE STÉAROYL-COENZYME INHIBITORS
DK2533050T3 (en)	2014-06-02	Treatment options for Fabry's disease
EP1976790A4 (en)	2012-05-02	ELEVATOR ACTUATOR
BRPI0719626A2 (en)	2014-06-24	'' COMPOUND ''
EP2141985A4 (en)	2012-01-25	TRANSGENIC ANIMAL MODELS FOR DISEASE
EP2035369A4 (en)	2011-02-16	THERAPEUTIC COMPOUNDS
EP2023729A4 (en)	2010-07-14	ORGANIC COMPOUNDS
FR2916627B1 (en)	2010-09-17	NECESSARY FOR TREATING A BLOOD CIRCULATION CONDUIT
EP2076207A4 (en)	2015-05-27	DIGITAL PLANNING OF ORTHODONTIC TREATMENT
EP2032566A4 (en)	2009-07-08	AZETIDINE DERIVATIVES AS DELTA-9 DEATURASE STÉAROYL-COENZYME INHIBITORS
EP2067285A4 (en)	2013-06-12	TRANSMISSION USING A PLURALITY OF PROTOCOLS
EP2088861A4 (en)	2010-07-07	BENZIMIDAZOLE COMPOUNDS
FR2898646B1 (en)	2011-12-16	STRUCTURE OF TAIL-D'ARONDE OF A BLOWER.
BRPI0717671A2 (en)	2014-02-25	"DENTAL IRRIGATOR"
EP1977009A4 (en)	2009-06-03	ADENOVIRUS ADIPOGENES AS A BIOMARKER OF A DISEASE
EP1986660A4 (en)	2009-08-26	HEXOSE-BASED COMPOUNDS FOR TREATING CANCER
EP2210621A4 (en)	2010-11-17	COMPOSITION FOR TREATING JOINT DISEASE
EP2047859A4 (en)	2010-05-05	TREATMENT OF ISCHEMIC DISEASE USING ERYTHROPOIETIN
EP1960549A4 (en)	2010-01-13	Fc-GAMMA POLYMORPHISMS FOR PREDICTING A DISEASE AND THE RESULTS OF TREATMENT
EP2162377A4 (en)	2014-05-21	ELEVATOR SHEATH
EP2252277A4 (en)	2012-03-21	ACETYL-MIMETIC COMPOUNDS FOR INHIBITING ISOPRENYL-S-CYSTEINEYL METHYLTRANFERASE

Legal Events

Date	Code	Title	Description
2009-03-06	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2009-04-08	17P	Request for examination filed	Effective date: 20090109
2009-04-08	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
2009-04-08	AX	Request for extension of the european patent	Extension state: AL BA HR MK RS
2009-04-22	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: ANACOR PHARMACEUTICALS, INC.
2009-06-24	RIC1	Information provided on ipc code assigned before grant	Ipc: A61Q 11/00 20060101ALI20090519BHEP Ipc: A61K 31/69 20060101ALI20090519BHEP Ipc: C07F 5/05 20060101ALI20090519BHEP Ipc: C07F 5/02 20060101ALI20090519BHEP Ipc: C07F 5/00 20060101AFI20090519BHEP
2009-12-04	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1129680 Country of ref document: HK
2010-08-04	A4	Supplementary search report drawn up and despatched	Effective date: 20100706
2011-09-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2011-10-12	18D	Application deemed to be withdrawn	Effective date: 20110208
2016-01-08	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1129680 Country of ref document: HK